The Spacehaler(TM) for delivery of salbutamol: A comparison with the standard metered-dose inhaler plus Volumatic(TM) spacer device

Respiratory Medicine

Volumn 91, Issue 5, 1997, Pages 311-316

  Gunawardena, K A ^a   Sohal, T ^b   Jones, J I ^c   Upchurch, F C ^c   Crompton, G K ^d  

^a Chiltern House   (United Kingdom)

^b Chiltern International Ltd   (United Kingdom)

^c Evans Medical Ltd   (United Kingdom)

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SALBUTAMOL; BRONCHODILATING AGENT;

ADULT; AEROSOL; AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DOSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INHALER; INTERMETHOD COMPARISON; MALE; OBSTRUCTIVE AIRWAY DISEASE; PATIENT SATISFACTION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUESTIONNAIRE; COMPARATIVE STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; LUNG; MIDDLE AGED; NEBULIZER; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; VITAL CAPACITY;

ADULT; AGED; ALBUTEROL; ASTHMA; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG DELIVERY SYSTEMS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; VITAL CAPACITY;

EID: 0030612799     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(97)90035-4     Document Type: Article

References (12)

1. Newhouse MT, Dolovich MB. Control of asthma by aerosols. N Eng J Med 1986; 315: 870-874.
2. Morén F. Drug deposition of pressurised inhalation aerosols. Eur J Res Dis 1982; 119 (Suppl.): 51-55.
3. Newman SP, Pavia D, Morén F, Sheahan NF, Clarke SW. Deposition of pressurised aerosols in the human respiratory tract. Thorax 1981; 36: 52-55.
4. Crompton GK. Problems patients have using pressurised aerosol inhalers. Eur J Res Dis 1982; 119 (Suppl.): 101-104.
5. Newman SP, Morén F, Pavia D, Little F, Clarke SW. Deposition of pressurised suspension aerosols inhaled through extension devices. Am Rev Respir Dis 1981; 124: 317-320.
6. Salzman GA, Pyszczynski DR. Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber™. J Allergy Clin Immunol 1988; 81: 424-428.
7. Chipps BE, Naumann PF, Wong GA, Raabe OG. Clinical comparison of Gentlehaler™ actuator and aerochamber spacer for the metered-dose inhaler use by asthmatics. Respir Care 1992; 37: 1414-1422.
8. Newman SP, Clark SW. Bronchodilator delivery from Gentlehaler™, a new low-velocity pressurised aerosol inhaler. Chest 1993; 103: 1442-1446.
9. Rogers DF, Ganderton D. Determining equivalence of inhaled medications. Respir Med 1995; 89: 253-261.
10. Diletti E, Hauschre D, Steinijans VW. Sample size determination for bioequivalence assessment by means of confidence intervals. Int J Clin Pharm, Therapy Toxicol 1991; 29: 1-8.
11. Phillips KE. Power of the two one-sided tests procedure in bioequivalence. J Pharmacokinet Biopharm 1990; 18: 137-143.
12. Schuirmann DJ, A comparison of the two onesided tests procedures and power approach to assessing the bio-equivalence of average bio-availability. J Pharmacokinet Biopharm 1987; 15: 657-680.